PL1694273T3 - Sposoby postępowania dietetycznego w zespole jelita drażliwego i w zespole złego wchłaniania węglowodanów - Google Patents

Sposoby postępowania dietetycznego w zespole jelita drażliwego i w zespole złego wchłaniania węglowodanów

Info

Publication number
PL1694273T3
PL1694273T3 PL04812935T PL04812935T PL1694273T3 PL 1694273 T3 PL1694273 T3 PL 1694273T3 PL 04812935 T PL04812935 T PL 04812935T PL 04812935 T PL04812935 T PL 04812935T PL 1694273 T3 PL1694273 T3 PL 1694273T3
Authority
PL
Poland
Prior art keywords
methods
bowel syndrome
irritable bowel
dietary management
carbohydrate malabsorption
Prior art date
Application number
PL04812935T
Other languages
English (en)
Inventor
Sean Farmer
Andrew R. Lefkowitz
Original Assignee
Ganeden Biotech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ganeden Biotech, Inc. filed Critical Ganeden Biotech, Inc.
Publication of PL1694273T3 publication Critical patent/PL1694273T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL04812935T 2003-12-05 2004-12-03 Sposoby postępowania dietetycznego w zespole jelita drażliwego i w zespole złego wchłaniania węglowodanów PL1694273T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US52807403P 2003-12-05 2003-12-05
US10/915,030 US7767203B2 (en) 1998-08-07 2004-08-09 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
EP04812935.7A EP1694273B1 (en) 2003-12-05 2004-12-03 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
PCT/US2004/040513 WO2005055934A2 (en) 2003-12-05 2004-12-03 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption

Publications (1)

Publication Number Publication Date
PL1694273T3 true PL1694273T3 (pl) 2020-11-16

Family

ID=34681545

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04812935T PL1694273T3 (pl) 2003-12-05 2004-12-03 Sposoby postępowania dietetycznego w zespole jelita drażliwego i w zespole złego wchłaniania węglowodanów

Country Status (13)

Country Link
US (8) US7767203B2 (pl)
EP (1) EP1694273B1 (pl)
AU (1) AU2004296815B2 (pl)
CA (1) CA2548149C (pl)
CY (1) CY1123296T1 (pl)
DK (1) DK1694273T3 (pl)
ES (1) ES2806098T3 (pl)
HU (1) HUE051079T2 (pl)
LT (1) LT1694273T (pl)
PL (1) PL1694273T3 (pl)
PT (1) PT1694273T (pl)
SI (1) SI1694273T1 (pl)
WO (1) WO2005055934A2 (pl)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374753B1 (en) * 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
CA2441192C (en) * 2001-03-23 2009-05-19 Ajinomoto Co., Inc. The use of lysine for the prevention or treatment of stress-induced diseases
BR0312501A (pt) * 2002-07-10 2005-04-12 Warner Lambert Co Combinação de um inibidor alostérico ou metaloproteinase de matriz-13 com um inibidor de ciclooxigenase-2 diferente de celecoxib ou valdecoxib
US7611480B2 (en) * 2003-04-24 2009-11-03 Levy Mark M Gastrointestinal bioreactor
US7276115B1 (en) * 2003-07-17 2007-10-02 Cathey Timothy D Conformable coating
US7731976B2 (en) * 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7749509B2 (en) * 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
US8192733B2 (en) 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7854927B2 (en) * 2004-05-11 2010-12-21 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US8092793B2 (en) * 2004-12-15 2012-01-10 Qingdao East Sea Pharmaceuticals, Ltd. Treating inflammatory bowel disease with live bacteria
CN100569243C (zh) * 2004-12-15 2009-12-16 北京天施康医药科技发展有限公司 一种治疗溃疡性结肠炎的凝结芽孢杆菌活菌制剂的制造方法和应用
US8246946B2 (en) * 2005-09-27 2012-08-21 Cobb & Associates Treatment of bipolar disorder utilizing anti-fungal compositions
US20090175933A1 (en) * 2005-10-07 2009-07-09 Colocaps Pty Ltd Preparation for the treatment of diarrhoea
ITRM20050531A1 (it) 2005-10-26 2007-04-27 D M G Italia S R L Dispositivo medico comprendente lactobacilli e simeticone per il trattamento delle patologie gastrointestinali.
DE102006013624B4 (de) * 2005-11-23 2012-03-15 Pro Natura Gesellschaft für gesunde Ernährung mbH Mittel zur Anwendung bei Fructoseintoleranz
DE102006012244A1 (de) * 2005-11-16 2007-05-31 Pro Natura Gesellschaft für gesunde Ernährung mbH Mittel zur Anwendung bei Fructoseintoleranz
WO2007057749A2 (en) 2005-11-16 2007-05-24 Pro Natura Gesellschaft für gesunde Ernährung mbH Agent for use in the case of fructose intolerance
KR101252635B1 (ko) * 2006-04-20 2013-04-10 (주)아모레퍼시픽 리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
ES2616012T3 (es) 2006-05-01 2017-06-09 Napo Pharmaceuticals, Inc. Composiciones para tratar o prevenir enfermedad inflamatoria del intestino
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
SI2241318T1 (sl) * 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
US7556832B2 (en) * 2006-05-09 2009-07-07 Kracke Donald R Process and formula for treating irritable bowel syndrome
CN101095698B (zh) * 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
CN101134052A (zh) * 2006-11-17 2008-03-05 青岛东海药业有限公司 酪酸梭菌、凝结芽孢杆菌、双歧杆菌在制备防治口腔溃疡药物中的应用
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
ITMI20070649A1 (it) * 2007-03-30 2008-09-30 Farmaceutici S R L Composizioni per il riequlibrio della flora batterica intestinale con attivita' antidiarroica antinfiammatoria e lenitiva delle intolleranze al lattosio ed ai suoi derivati
US9420807B2 (en) * 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
US7722628B2 (en) * 2007-04-04 2010-05-25 Ethicon Endo-Surgery, Inc. Device for plicating and fastening gastric tissue
US7951159B2 (en) * 2007-04-04 2011-05-31 Ethicon Endo-Surgery, Inc. Method for plicating and fastening gastric tissue
US7803165B2 (en) * 2007-04-04 2010-09-28 Ethicon Endo-Surgery, Inc. Device for plicating and fastening gastric tissue
AU2015200006B2 (en) * 2007-08-29 2016-12-01 Ganeden Biotech, Inc. Baked Goods
WO2009032121A1 (en) * 2007-08-29 2009-03-12 Ganeden Biotech, Inc. Compositions and methods for enhancing paper product degradation
EP3628164A1 (en) * 2007-08-29 2020-04-01 Ganeden Biotech, Inc. Baked goods
DE112008002398A5 (de) * 2007-09-22 2010-07-29 Bayer Consumer Care Ag Zusammensetzung mit Wirkstoffkombination aus einem Laxans und einem Entschäumer zur Behandlung von Obstipation
US8236297B2 (en) * 2007-10-11 2012-08-07 Kenneth Manzo Method of treating lactose intolerance using genetically engineered bacteria
ES2868135T3 (es) * 2007-10-16 2021-10-21 Ganeden Biotech Inc Composiciones de bebidas
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
EP2293802A4 (en) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc LACTOSE COMPOSITIONS HAVING REDUCED LACTOSE CONTENT
CA2740423C (en) 2008-10-16 2020-09-08 Ganeden Biotech, Inc. Probiotic grain-based compositions
DE202008015430U1 (de) * 2008-11-20 2009-12-24 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Verdauungsstörungen
EP2400839B1 (en) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2424550B1 (en) 2009-04-29 2017-06-07 Ganeden Biotech, Inc. Bacterial cell membrane formulation
US8506952B2 (en) * 2009-07-03 2013-08-13 James Madison Innovations, Inc. Probiotic compositions and process thereof
DE102010009582A1 (de) 2010-02-05 2011-08-11 Vitacare GmbH & Co. KG, 60318 Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz
WO2011130487A1 (en) 2010-04-14 2011-10-20 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2422627A1 (en) 2010-08-26 2012-02-29 Unilever N.V. An ice cream composition and process of preparation thereof
US9678058B2 (en) * 2010-09-03 2017-06-13 Anastasia Rigas Diagnostic method and breath testing device
WO2012135499A1 (en) * 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
EP3145403A4 (en) * 2012-03-14 2018-01-24 Anastasia Rigas Breath analyzer and breath test methods
RU2508768C1 (ru) * 2012-11-26 2014-03-10 Олег Иванович Квасенков Способ производства консервов "солянка овощная из свежей капусты со свиными копченостями"
RU2508732C1 (ru) * 2012-11-26 2014-03-10 Олег Иванович Квасенков Способ получения консервов "солянка овощная из свежей капусты"
RU2508741C1 (ru) * 2012-11-26 2014-03-10 Олег Иванович Квасенков Способ производства консервированного продукта "солянка овощно-грибная из квашеной капусты"
RU2508742C1 (ru) * 2012-11-26 2014-03-10 Олег Иванович Квасенков Способ выработки консервированного продукта "солянка овощно-грибная из квашеной капусты"
RU2508740C1 (ru) * 2012-11-26 2014-03-10 Олег Иванович Квасенков Способ выработки обогащенных консервов "солянка овощно-грибная из свежей капусты"
RU2508728C1 (ru) * 2012-11-26 2014-03-10 Олег Иванович Квасенков Способ получения консервов "капуста свежая с грибами"
RU2508793C1 (ru) * 2012-11-26 2014-03-10 Олег Иванович Квасенков Способ производства консервов "сосиски рижские с капустой"
RU2508821C1 (ru) * 2012-11-27 2014-03-10 Олег Иванович Квасенков Способ производства консервов "котлеты обжаренные в чилийском соусе"
RU2508822C1 (ru) * 2012-12-04 2014-03-10 Олег Иванович Квасенков Способ выработки консервов "котлеты обжаренные в чилийском соусе"
RU2514562C1 (ru) * 2013-04-22 2014-04-27 Олег Иванович Квасенков Способ выработки консервов "мясо с гарниром"
RU2514565C1 (ru) * 2013-04-29 2014-04-27 Олег Иванович Квасенков Способ производства консервов "сердце в красном основном соусе с тушеной капустой"
RU2514564C1 (ru) * 2013-04-29 2014-04-27 Олег Иванович Квасенков Способ производства закусочных консервов "ласточкино гнездо"
US9402885B2 (en) * 2013-07-15 2016-08-02 Alfa Wassermann S.P.A. Method of treating GERD with alpha and beta galactosidases
EP3185877B1 (en) * 2014-08-29 2020-04-01 Muhammed Majeed Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
US9579352B2 (en) * 2014-11-10 2017-02-28 Sami Labs Limited Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC-37-01, MTCC 5856
JP6629875B2 (ja) * 2016-01-07 2020-01-15 サミ ラブズ リミテッド バチルス・コアグランスｓｂｃ３７−０１，ｍｔｃｃ５８５６を使用する下痢型過敏性腸症候群の治療管理の方法
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
US10166261B2 (en) * 2016-06-30 2019-01-01 Sami Labs Limited Bacillus coagulans MTCC 5856 for the management of major depressive disorder
GB201614415D0 (en) 2016-08-24 2016-10-05 Pepsis Ltd Enzymes for the treatment of human enterometabolic dysfunction
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
US10269116B2 (en) * 2016-12-26 2019-04-23 Intel Corporation Proprioception training method and apparatus
US11857510B2 (en) 2017-05-31 2024-01-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating congenital diarrhea disorder
JP7328153B2 (ja) * 2017-05-31 2023-08-16 ナポ ファーマシューティカルズ インク． 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物
NZ759306A (en) * 2017-06-09 2022-07-29 Sami Labs Ltd Compositions and methods for reducing flatulence
US20210128567A1 (en) * 2017-08-29 2021-05-06 Flaask, Llc Compositions and Methods for Cognitive, Immune and Digestive Support in Patients with Autism Spectrum Disorder
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
EP3823651A4 (en) 2018-07-19 2022-04-27 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MICROBIAL TRANSPLANTATION
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
EP4011290A1 (en) 2018-12-10 2022-06-15 Anastasia Rigas Breath analyzer devices and breath test methods
US12150752B2 (en) 2018-12-10 2024-11-26 Anastasia Rigas Hydrogen breath analyzer and breath test method
US11865151B2 (en) * 2019-02-14 2024-01-09 Gutsybio Inc. Live biotherapeutics for the treatment of carbohydrate disorders
WO2020204910A1 (en) * 2019-04-02 2020-10-08 Muhammed Majeed Stable probiotic composition for the management of lactose intolerance
JP7390398B2 (ja) * 2019-04-02 2023-12-01 サミ－サビンサ グループ リミテッド グルテン不耐性の治療管理のための方法および組成物
US11202810B2 (en) * 2019-04-02 2021-12-21 Sami-Sabinsa Group Limited Stable probiotic composition for the management of lactose intolerance
SG11202111168UA (en) 2019-04-09 2021-11-29 Dermbiont Inc Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
WO2020231397A1 (en) * 2019-05-13 2020-11-19 Muhammed Majeed Fructophilic lactic acid producing bacteria
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
CN115322931B (zh) * 2022-08-19 2023-04-25 华南农业大学 一株能够抑制α-葡萄糖苷酶和/或α-淀粉酶活性的凝结魏兹曼杆菌及其应用
KR20240038852A (ko) * 2022-09-16 2024-03-26 일동제약(주) 신규한 복합 균주 및 이의 용도
CN117736943B (zh) * 2024-02-20 2024-05-24 山东中科嘉亿生物工程有限公司 一种改善肠易激综合征的复合菌剂及其制备方法和用途

Family Cites Families (156)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091572A (en) 1962-07-16 1963-05-28 Schering Corp Gentamycin and method of production
GB1040278A (en) 1963-10-15 1966-08-24 Analyses Et De Rech S Biolog M Bacterial compositions for the regeneration of the intestinal microflora
US3629073A (en) * 1969-04-01 1971-12-21 Baxter Laboratories Inc Acid-active lactose
US3840684A (en) 1970-03-13 1974-10-08 Gen Foods Corp Decaffeinated coffee
US3718739A (en) * 1971-06-15 1973-02-27 Baxter Laboratories Inc Treating lactase deficiency with an active lactase
US3919049A (en) * 1974-06-27 1975-11-11 Tokyo Tanabe Co Process for preparing {62 -galactosidase
US4323651A (en) 1974-12-04 1982-04-06 R. J. Reynolds Tobacco Company Thermostable lactase derived from bacillus
US4179335A (en) * 1974-12-04 1979-12-18 R. J. Reynolds Tobacco Company Thermostable lactase derived from Bacillus coagulans
US4210672A (en) 1976-04-02 1980-07-01 Seikenkai Preparation of yogurt
US4144346A (en) 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4110477A (en) 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
US4321258A (en) 1980-08-13 1982-03-23 Dunlap Dorsey S Non-toxic insecticide
CA1206108A (en) 1981-03-06 1986-06-17 Shuichi Aiba Process for transforming microorganism by means of plasmid introduction
US4751085A (en) 1984-08-29 1988-06-14 Gaull Gerald E Human nutritional compositions containing taurine and vitamins and/or minerals
US4816252A (en) 1985-04-15 1989-03-28 Protein Technology, Inc. Product and process for transferring passive immunity to newborn domestic animals using ultrafiltered whey containing immunoglobulins
US5066491A (en) 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
US4834974A (en) 1986-01-13 1989-05-30 Protein Technologies, Inc. Immunologically active whey fraction and recovery process
JPS6261572A (ja) 1985-09-12 1987-03-18 Nippon Oil & Fats Co Ltd スプレツドおよびその製法
US4756913A (en) 1985-09-30 1988-07-12 Khorkova Evgenia A Sour milk product
US4956177A (en) 1985-11-04 1990-09-11 Microlife Technics, Inc. Method for inhibiting fungi
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
ES2007350A6 (es) 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
JP2806522B2 (ja) 1987-09-04 1998-09-30 日本食品化工株式会社 分岐フラクトオリゴ糖の製造方法
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
JPS6483025A (en) 1987-09-24 1989-03-28 Fujio Hayashi Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
DK686187D0 (da) 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
JPH01199575A (ja) * 1988-02-04 1989-08-10 Rikagaku Kenkyusho 新規なサイクロマルトデキストリン・グルカノトランスフェラーゼ及びその製造法
US5443826A (en) 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
IT1227154B (it) 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
GB8825814D0 (en) 1988-11-04 1988-12-07 Ici Plc Polyester polymers & aqueous dispersions thereof
AT391323B (de) 1989-03-10 1990-09-25 Jungbunzlauer Ag Mikroorganismus der species bacillus coagulans sowie ein verfahren zur herstellung von optisch reiner l(+)-milchsaeure
FR2656314B1 (fr) 1989-12-22 1992-04-17 Bp Chemicals Snc Catalyseur a base de zirconium supporte sur du chlorure de magnesium, procede de preparation et utilisation du catalyseur dans la polymerisation des olefines.
DE4001611C1 (pl) * 1990-01-20 1991-02-28 Skw Trostberg Ag, 8223 Trostberg, De
US5266315A (en) 1990-05-07 1993-11-30 Kabushiki Kaisha Miyarisan Seibutsu Igaku Kenkyusho Composite for Clostridium difficile diarrhea and pseudomembranous colitis
JPH0678367B2 (ja) 1990-05-15 1994-10-05 呉羽化学工業株式会社 食物繊維、その製造法及びその食物繊維を含有する生理活性剤
US5200336A (en) * 1990-07-02 1993-04-06 New England Biolabs, Inc. Restriction endonuclease obtainable foam bacillus coagulans and a process for producing the same
WO1992006701A1 (en) 1990-10-18 1992-04-30 Huffstutler, M., Conrad, Jr. Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use
FR2677038B1 (fr) 1991-06-03 1994-08-12 Bel Fromageries Additif alimentaire pour l'alimentation humaine et animale et aliments le contenant.
DE4132296C1 (en) 1991-09-27 1992-12-17 Karl Heinz 8081 Schoengeising De Hoelzel Enzymic metabolic prod. prepn. for intestinal disorders etc. - obtd. from pathogenic lacto- and bifido- bacteria from the gut
GB2261372A (en) 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
IT1262927B (it) 1992-01-14 1996-07-22 Consiglio Nazionale Ricerche Batteri sporgenti e loro impiego come probiotici
CA2063499C (en) 1992-03-19 1996-06-18 Leon Edward St. Pierre Ingestible polymeric phosphonium salts for the lowering of blood cholesterol
JP3459837B2 (ja) 1992-05-12 2003-10-27 太陽化学株式会社 生菌粉末
US5902617A (en) * 1992-05-19 1999-05-11 Pabst; Patrea L. Enzyme supplemented baby formula
WO1994011492A1 (en) 1992-11-12 1994-05-26 Chr. Hansen's Laboratory, Inc. Method of favorably modifying poultry intestinal microflora
US5413785A (en) 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
US5449523A (en) 1993-04-20 1995-09-12 The Ohio State University Research Foundation Process for the manufacture of a calcium fortified yogurt with improved heat stability
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US6103246A (en) 1993-06-03 2000-08-15 Tisdale; Carrie J. Creams and lotions containing emu oil
JP2510943B2 (ja) 1993-06-07 1996-06-26 株式会社ドクターマインツ 痩身用食品
CA2143648C (en) * 1993-07-14 2001-10-16 John R. Brunnquell Low cholesterol eggs
US6428786B1 (en) * 1993-09-28 2002-08-06 Mcneil-Ppc, Inc. Composition and method for lactose hydrolysis
DE4336050C2 (de) 1993-10-22 1995-11-16 Onken Gmbh Tierfutter, insbesondere Alleinfutter für Katzen und Hunde
JP3381010B2 (ja) 1994-05-10 2003-02-24 株式会社林原生物化学研究所 プロポリスエキスを含有する発酵物とその製造方法並びに用途
US5589381A (en) 1994-06-30 1996-12-31 Rutgers, The State University Of New Jersey Bacillus licheniformis producing antifungal agents and uses thereof for control of phytopathogenic fungi
AUPM864894A0 (en) 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
US5531989A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5531988A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
JPH08175921A (ja) 1994-12-22 1996-07-09 Idemitsu Kosan Co Ltd 農園芸用殺菌剤組成物
US5534253A (en) 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
US5785990A (en) 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
JPH09194384A (ja) 1996-01-19 1997-07-29 Snow Brand Milk Prod Co Ltd ミネラル吸収促進剤
CA2245810A1 (en) 1996-02-14 1997-08-21 The Procter & Gamble Company Urogenital and intestinal compositions
AUPN881396A0 (en) 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
DK0862863T4 (da) 1997-01-09 2008-12-01 Nestle Sa Kornprodukt indeholdende probiotika
US6132710A (en) 1997-03-17 2000-10-17 Probiotix, Inc. Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof
ATE493139T1 (de) 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US7507402B1 (en) 1997-04-18 2009-03-24 Ganeden Biotech, Inc. Topical use of probiotic Bacillus spores to prevent or control microbial infections
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US7374753B1 (en) 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
JP2002502430A (ja) 1997-06-03 2002-01-22 ガネデン バイオテック，インコーポレイテッド Ｓｉｄｓに関連する細菌感染を処置するための共生乳酸細菌
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
JP3768694B2 (ja) 1997-08-18 2006-04-19 コーア株式会社 Ｂａｃｉｌｌｕｓｓｐ代謝物含有材の製造方法
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
JP3652866B2 (ja) 1997-12-18 2005-05-25 花王株式会社 有胞子乳酸菌を含有する飲料
US6107291A (en) 1997-12-19 2000-08-22 Amgen Inc. Azepine or larger medium ring derivatives and methods of use
US5895672A (en) 1998-01-13 1999-04-20 Cooper; Barry Patrick Wesley Product and process for preparing a tea extract
US5928664A (en) 1998-02-11 1999-07-27 Fuisz Technologies Ltd. Consumable gummy delivery system
JP3324979B2 (ja) 1998-02-17 2002-09-17 浅田商事株式会社 芝草の刈りかすおよびサッチを分解するバチルス、そのバチルスを含有する微生物資材
EP1067945B1 (en) 1998-04-01 2006-01-04 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
US6811786B1 (en) 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
JPH11335285A (ja) 1998-05-25 1999-12-07 Toyotama Koryo Kk 整腸・便秘改善剤およびこれを含有する飲食物並びに動物用飼料
AT407008B (de) * 1998-08-06 2000-11-27 Viernstein Helmut Dr Formulierungen mit probiotisch wirksamen mikroorganismen
CA2339643A1 (en) 1998-08-07 2000-02-17 Ganeden Biotech, Inc. Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
JP2000093162A (ja) 1998-09-24 2000-04-04 Kao Corp 有胞子乳酸菌の培養方法
US6080401A (en) 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
IT1306201B1 (it) 1999-01-14 2001-05-30 Giuliani Spa Composizione adatta quale integratore alimentare e per il trattamentoterapeutico di disturbi intestinali e di alterazioni della flora
EP1020123A1 (en) 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
AU780367B2 (en) 1999-04-14 2005-03-17 Ganeden Biotech, Inc. Methods for inhibiting microbial infections associated with sanitary products
US20040161422A1 (en) 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
EP1212093B1 (en) 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications
JP4082827B2 (ja) 1999-09-13 2008-04-30 日東電工株式会社 基板の異物除去装置
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1229923A1 (en) 1999-11-08 2002-08-14 Ganeden Biotech, Inc. Inhibition of pathogens by bacillus coagulans strains
EP1112693B1 (en) 1999-12-30 2006-03-22 Kerry Group Services Ltd Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
JP2001252012A (ja) 2000-03-15 2001-09-18 Otsuka Shokuhin Kk 長期間チルド保存可能な乳酸菌飲料およびその製造方法
JP3363438B2 (ja) 2000-05-02 2003-01-08 ビオフェルミン製薬株式会社 噴霧乾燥による菌体乾燥物
AU2001272968C1 (en) 2000-06-22 2008-06-05 Amgen Inc. Il-17 molecules and uses thereof
US20020150594A1 (en) 2000-06-26 2002-10-17 Maxygen, Inc. Methods and compositions for developing spore display systems for medicinal and industrial applications
WO2002018574A2 (en) 2000-08-25 2002-03-07 North Shore-Long Island Jewish Research Institute Human interleukin-four induced protein
US7024497B1 (en) 2000-09-07 2006-04-04 Adaptec, Inc. Methods for accessing remotely located devices
US9292516B2 (en) 2005-02-16 2016-03-22 Sonic Solutions Llc Generation, organization and/or playing back of content based on incorporated parameter identifiers
JP2002085009A (ja) 2000-09-14 2002-03-26 Unicafe Inc 納豆末を用いた腸内活性化食品
JP2002114671A (ja) 2000-10-04 2002-04-16 Taisho Pharmaceut Co Ltd サイトカイン産生抑制剤
JP3733896B2 (ja) * 2001-01-30 2006-01-11 株式会社デンソー 振動溶着方法
US20030185811A1 (en) 2001-02-06 2003-10-02 Steve Teasdale Herbal extract and preparation thereof
AU2002250236A1 (en) 2001-03-02 2002-09-19 Medimmune, Inc. Cd2 antagonists for treatment of autoimmune or inflammatory disease
US6599555B2 (en) 2001-03-08 2003-07-29 Bocabear Foods, Inc. Process for making a reduced-calorie fruit and/or vegetable spread
CA2466022A1 (en) 2001-11-05 2003-05-15 Ganeden Biotech, Inc. Probiotic compositions
EP1448127A1 (en) 2001-11-06 2004-08-25 Maxim Pharmaceuticals, Inc. Compositions for the treatment of infectious diseases
EP1344458A1 (en) 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
WO2004004747A1 (ja) 2002-07-09 2004-01-15 Decentwork Inc. 整腸性組成物及び整腸健康飲料並びに大腸内洗浄液
US20040010510A1 (en) 2002-07-10 2004-01-15 Timo Hotti Method and system for database synchronization
CA2493934A1 (en) 2002-07-19 2004-01-29 Suedzucker Aktiengesellschaft Mannheim/Ochsenfurt Isomaltulose-containing instant beverage powder
TWI228974B (en) 2002-09-04 2005-03-11 Genmont Biotech Inc Beverage containing lactobacillus and the manufacturing method thereof
US20040071685A1 (en) 2002-10-09 2004-04-15 Devin Houston Compositions and methods for increasing the bioavailability of plant polyphenols
CN1221187C (zh) 2002-12-13 2005-10-05 景岳生物科技股份有限公司 含乳酸菌的饮用品及其制造方法
US20040175459A1 (en) 2003-03-06 2004-09-09 Te-Chih Ting Method for producing an aqueous beverage containing sporogenous lactic bacteria
EP1759597B1 (en) 2003-03-13 2009-01-21 Kirin Holdings Kabushiki Kaisha Probiotic composition
JP2004337125A (ja) 2003-05-19 2004-12-02 Ajinomoto Co Inc 有胞子乳酸菌胞子を含有するインスタントスープ
JPWO2005007179A1 (ja) 2003-07-18 2006-08-31 株式会社トーヨー技術研究所 ハスの破砕物および／または抽出物と、乳酸菌とを含む組成物
CA2535951A1 (en) 2003-08-14 2005-03-03 The Bio Balance Corporation Bacterial strains, compositions including same and probiotic use thereof
EP1683294A4 (en) 2003-11-14 2007-01-17 Sonic Solutions SAFE TRANSFER OF CONTENTS TO DESCRIBABLE MEDIA
US7483583B2 (en) 2003-12-16 2009-01-27 Infocus Corporation System and method for processing image data
JP2007082403A (ja) 2004-03-26 2007-04-05 Nippon Medicine:Kk ユッカ抽出物、キラヤ抽出物及び乳酸菌の複合組成物を含有する飲食品及びその製造法
US7854927B2 (en) 2004-05-11 2010-12-21 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
JP2007308373A (ja) 2004-06-03 2007-11-29 Toyo Shinyaku:Kk 腸内菌叢改善剤
JP4296133B2 (ja) 2004-07-12 2009-07-15 カゴメ株式会社 チルド飲料およびその製造方法
KR20070086482A (ko) 2004-11-29 2007-08-27 알로에콥, 인크 식품 혼합물의 건조
JP4158771B2 (ja) 2005-01-07 2008-10-01 ブラザー工業株式会社 通信端末装置
CN101128122B (zh) 2005-02-23 2011-02-09 大塚制药株式会社 基于茶的发酵饮料和茶饮料
JP2006254837A (ja) 2005-03-18 2006-09-28 Kyoto Institute Of Technology 乳酸菌機能茶、乳酸菌機能茶抽出物、乳酸菌機能茶葉乾燥物
ITBG20050025A1 (it) 2005-05-13 2006-11-14 Abb Service Srl Interruttore con migliorate caratteristiche di intercambiabilita' del comando.
JP2007000140A (ja) 2005-05-25 2007-01-11 Suntory Ltd 乳酸菌を用いたコーヒー生豆の処理方法
JP4332743B2 (ja) 2005-08-12 2009-09-16 天野実業株式会社 発酵食品由来の有胞子性乳酸菌を含有する乾燥食品
US7555715B2 (en) 2005-10-25 2009-06-30 Sonic Solutions Methods and systems for use in maintaining media data quality upon conversion to a different data format
EP1967196A4 (en) 2005-11-18 2009-10-14 Idemitsu Kosan Co BACILLUS THURINGIENSIS CONTAINING MEANS FOR THE CONTROL OF HARMFUL BACTERIA
US7758906B2 (en) 2006-01-20 2010-07-20 Kraft Foods Global Brands Llc Thickening system for products prepared with milk
JP5232404B2 (ja) 2006-06-07 2013-07-10 第一三共ヘルスケア株式会社 有胞子性乳酸菌含有抗感冒ウイルス又は抗インフルエンザウイルス用組成物
US7553486B2 (en) 2006-11-13 2009-06-30 Paul Theodore Finger Anti-VEGF treatment for radiation-induced vasculopathy
US20080166449A1 (en) 2006-11-29 2008-07-10 Cadbury Adams Usa Llc Confectionery compositions including an elastomeric component and a saccharide component
CN105796607A (zh) 2007-02-28 2016-07-27 Mjn 美国控股有限责任公司 用于儿童或婴幼儿的含有灭活益生菌的产品
US20100098806A1 (en) 2007-03-13 2010-04-22 Vdf Futureceuticals, Inc. Compositions and Methods of Dehydrated Food Fortification
US20080305096A1 (en) 2007-06-07 2008-12-11 Unicity International, Inc. Method and composition for providing controlled delivery of biologically active substances
EP3628164A1 (en) 2007-08-29 2020-04-01 Ganeden Biotech, Inc. Baked goods
ES2868135T3 (es) 2007-10-16 2021-10-21 Ganeden Biotech Inc Composiciones de bebidas
US20090202683A1 (en) 2008-02-11 2009-08-13 Jennyfer Reed Matteson Confections with chewy, sour and creamy attributes, and methods to make and use the same
CA2740423C (en) 2008-10-16 2020-09-08 Ganeden Biotech, Inc. Probiotic grain-based compositions
EP2424550B1 (en) 2009-04-29 2017-06-07 Ganeden Biotech, Inc. Bacterial cell membrane formulation
WO2011130487A1 (en) 2010-04-14 2011-10-20 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US20150044317A1 (en) 2012-02-28 2015-02-12 Ganeden Biotech, Inc. Topical Compositions for Reducing Visible Signs of Aging and Methods of Use Thereof
WO2013130829A1 (en) 2012-02-28 2013-09-06 Ganeden Biotech, Inc. Cosmetic compositions
US20150313951A1 (en) 2014-05-01 2015-11-05 Ganeden Biotech, Inc. Functional foods containing bacillus coagulans and non-dairy milk-like compositions

Also Published As

Publication number Publication date
US20170035813A1 (en) 2017-02-09
US8343484B2 (en) 2013-01-01
AU2004296815B2 (en) 2011-06-30
US20090181000A1 (en) 2009-07-16
ES2806098T3 (es) 2021-02-16
PT1694273T (pt) 2020-07-21
US20050100535A1 (en) 2005-05-12
LT1694273T (lt) 2020-07-27
US7767203B2 (en) 2010-08-03
US20190060378A1 (en) 2019-02-28
EP1694273A4 (en) 2012-05-23
US11439672B2 (en) 2022-09-13
US20130344046A1 (en) 2013-12-26
US20080112942A1 (en) 2008-05-15
DK1694273T3 (da) 2020-08-10
US7700093B2 (en) 2010-04-20
CA2548149A1 (en) 2005-06-23
EP1694273A2 (en) 2006-08-30
WO2005055934A3 (en) 2009-04-16
EP1694273B1 (en) 2020-06-03
HUE051079T2 (hu) 2021-03-01
SI1694273T1 (sl) 2020-10-30
US8273346B2 (en) 2012-09-25
US20090142315A1 (en) 2009-06-04
US20080038240A1 (en) 2008-02-14
CA2548149C (en) 2014-06-03
US9220736B2 (en) 2015-12-29
CY1123296T1 (el) 2021-12-31
WO2005055934A2 (en) 2005-06-23
US10111916B2 (en) 2018-10-30
AU2004296815A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
SI1694273T1 (sl) Postopki za dietetično upravljanje sindroma iritabilnega črevesa in malabsorpcije ogljikovih hidratov
PT1485078E (pt) Milnacipran para o tratamento do síndrome do intestino irritável
EP1569937A4 (en) INDIZOLYLPYRROLOTRIAZINES C-6 MODIFIED
GB0401363D0 (en) Hinge unit and hinge structure using the same
GB0227895D0 (en) Face detection
GB0227913D0 (en) Face detection
GB0227897D0 (en) Face detection
AU2003278474A8 (en) Systems and methods for accessing telescopes
PL372529A1 (pl) Atenuacja metapneumowirusa
GB0204775D0 (en) Component access
EP1581496A4 (en) 2-SUBSTITUTED 3-PROPENAMIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
IL175104A0 (en) The method of safe certification service
ZA200603254B (en) The method of safe certification service
GB2387804B (en) Component structure
GB0200757D0 (en) Diagnostic methods
GB2388185B (en) Hot cabinet
AU2003241037A1 (en) Methods for the detection of polymorphisms in human gpr50
GB0229336D0 (en) Multiplexer
AU2003288378A8 (en) Method for the secure transmission of messages or data between two entities
GB0224559D0 (en) Test
GB0211384D0 (en) Viscometers
GB2391649B (en) E-mail systems
GB2392219B (en) Connection for racks and the like
PL113019U1 (en) Complete door unit
GB0214842D0 (en) Diagnostic method